KALAMAZOO, Mich., Dec. 6 /PRNewswire-FirstCall/ -- Stryker announced today that the Board of Directors has declared a year-end cash dividend of thirty-three cents per share, an increase of 50% over the twenty- two cent dividend declared in December 2006. The dividend is payable January 31, 2008 to shareholders of record at the close of business on December 31, 2007.
“Our accelerating revenue growth in 2007 combined with our strong overall financial position have put us in the position of being able to significantly increase our dividend for the second year in a row,” commented Stephen P. MacMillan, President and Chief Executive Officer.
Stryker Corporation is one of the world’s leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company’s products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; and endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit the company web site at www.stryker.com.
CONTACT: Katherine A. Owen, Vice President, Strategy and Investor
Relations of Stryker, +1-269-385-2600
Web site: http://www.stryker.com/
